These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8746611)

  • 1. Prescribing rationale and budgetary outcomes associated with the introduction of a combined formulation of diclofenac sodium and misoprostol in Canada.
    Sclar DA; Robison LM; Maheu A; Skaer TL
    J Int Med Res; 1995; 23(6):439-48. PubMed ID: 8746611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.
    Kristiansen IS; Kvien TK; Nord E
    Arthritis Rheum; 1999 Nov; 42(11):2293-302. PubMed ID: 10555023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.
    Al MJ; Michel BC; Rutten FF
    Pharmacoeconomics; 1996 Aug; 10(2):141-51. PubMed ID: 10163417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diclofenac/misoprostol. Pharmacoeconomic implications of therapy.
    Plosker GL; Lamb HM
    Pharmacoeconomics; 1999 Jul; 16(1):85-98. PubMed ID: 10539124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacoeconomic comparison of misoprostol/diclofenac with diclofenac.
    Morant SV; Shield MJ; Davey PG; MacDonald TM
    Pharmacoepidemiol Drug Saf; 2002; 11(5):393-400. PubMed ID: 12271881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Economic evaluation of the use of diclofenac/misoprostol in the treatment of osteoarticular diseases].
    Soto Alvarez J
    An Med Interna; 2000 Sep; 17(9):477-84. PubMed ID: 11100534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.
    Davis R; Yarker YE; Goa KL
    Drugs Aging; 1995 Nov; 7(5):372-93. PubMed ID: 8573992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands.
    Al MJ; Maniadakis N; Grijseels EW; Janssen M
    Value Health; 2008; 11(4):589-99. PubMed ID: 18194404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy: clinical and economic implications of a single-tablet formulation of diclofenac/misoprostol.
    Goldstein JL; Larson LR; Yamashita BD
    Am J Manag Care; 1998 May; 4(5):687-97. PubMed ID: 10179922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage.
    Valentini M; Cannizzaro R; Poletti M; Bortolussi R; Fracasso A; Testa V; Sozzi M; Fornasarig M; Bortoluzzi F; Grazioli I
    J Clin Oncol; 1995 Oct; 13(10):2637-42. PubMed ID: 7595718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal-related healthcare resource usage associated with a fixed combination of diclofenac and misoprostol versus other NSAIDs.
    Rahme E; Joseph L; Kong SX; Watson DJ; Pellissier JM; LeLorier J
    Pharmacoeconomics; 2001; 19(5 Pt 2):577-88. PubMed ID: 11465302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diclofenac/misoprostol: the European clinical experience.
    McKenna F
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and gastroduodenal safety of a fixed combination of diclofenac and misoprostol in the treatment of arthritis.
    McKenna F
    Br J Rheumatol; 1995 Apr; 34 Suppl 1():11-8. PubMed ID: 7780674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic consequences of NSAID-induced gastropathy in the United Kingdom and commentary on the article by G. de Pouvourville.
    Knill-Jones RP
    Scand J Rheumatol Suppl; 1992; 96():59-62. PubMed ID: 1439626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada.
    Zabinski RA; Burke TA; Johnson J; Lavoie F; Fitzsimon C; Tretiak R; Chancellor JV
    Pharmacoeconomics; 2001; 19 Suppl 1():49-58. PubMed ID: 11280105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
    Bach GL; Stock KP; Hüdepohl M
    Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of misoprostol in the elderly: is the expense justified?
    Stucki G; Johannesson M; Liang MH
    Drugs Aging; 1996 Feb; 8(2):84-8. PubMed ID: 8845589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost effectiveness of misoprostol prophylaxis alongside long-term nonsteroidal anti-inflammatory drugs. Implications of the MUCOSA trial.
    Davey PJ; Meyer E
    Pharmacoeconomics; 2000 Mar; 17(3):295-304. PubMed ID: 10947304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of prophylactic treatment with Misoprostol in osteoarthritic patients treated with NSAIDs. The case of Belgium.
    Carrin GJ; Torfs KE
    Rev Epidemiol Sante Publique; 1990; 38(3):187-99. PubMed ID: 2118670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.